Tc-99m-sestamibi scan for parathyroid adenoma
The Tc-99m-Sestamibi scan is an imaging technique used to detect parathyroid adenomas by tracking uptake of a radioactive tracer in highly active cells.
The Tc-99m-Sestamibi scan is an imaging technique used to detect parathyroid adenomas by tracking uptake of a radioactive tracer in highly active cells.
In-depth explanation of Ga-68 PSMA PET imaging, a precise diagnostic tool for prostate cancer management.
Lu-177 PSMA therapy is a targeted radioactive treatment for advanced prostate cancer, minimizing damage to healthy tissues and improving patient quality of life.
Overview of PSMA-Ligand Therapy: a targeted cancer treatment approach utilizing a molecule that binds to PSMA on prostate cancer cells, delivering localized radiation to eradicate cancer while minimizing damage to healthy cells.
Immuno-PET imaging is a sophisticated technique that combines the sensitivity of PET scanning with the specificity of immunological targeting to visualize molecular processes, especially in cancer diagnosis and treatment.
Radiopharmaceuticals in pediatric imaging involve radioactive compounds used for diagnosing and treating health conditions in children, ensuring a balance between diagnostic effectiveness and safety.
Molecular targeted radiation (MTR) is a cutting-edge cancer treatment combining molecular biology and radiation to precisely target and destroy cancer cells.
Radioiodine refractory cancer is a type of thyroid cancer that does not respond to standard radioactive iodine treatment.
PET imaging in oncology detects and monitors cancer through metabolic activity using radioactive tracers.
Gastric Emptying Scintigraphy is a medical test that measures how quickly food exits the stomach and enters the small intestine, aiding in the diagnosis and management of digestive disorders like gastroparesis.